• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

UC Berkeley Bio Track Helps Faculty Launch Biotech Startups

by Syed Hamza Sohail 05/02/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • Berkeley SkyDeck, the global hub for entrepreneurship and a leading accelerator, today announced that it has welcomed the first three companies for its new SkyDeck LSEC Bio Track: AsparaGlue, Editpep, and MZR Neurotech.
  • The inaugural track, created in partnership with the UC Berkeley Life Sciences Entrepreneurship Center (LSEC) through LSEC’s new Venture Grant Program, will assist the UC Berkeley faculty-led teams to launch their own biotech and life sciences startup companies. The startups will receive investment from the SkyDeck Fund, access to Berkeley SkyDeck’s programming and network, and other critical resources. 

Leveraging Berkeley SkyDeck’s Network to Catapult Research into Viable Startups

Selected from a large and strong pool of applicants, each of the three newly formed companies will receive a minimum of $200,000: $100,000 as an academic translational grant from Berkeley LSEC and a $100,000 investment from the SkyDeck Fund, with an option to invest an additional $100,000. 

The LSEC Venture Grant awardees participating in the inaugural SkyDeck LSEC Bio Track are as follows:

AsparaGlue, founded by Professor and Chair of Bioengineering Phillip Messersmith and his postdoc Subhajit Pal. AsparaGlue has developed a superglue-like medical adhesive that can be uniquely used for both external wound closure as well as internal tissue adhesion and sealing. 

Editpep, founded by Innovative Genomics Institute Professor Ross Wilson and Berkeley Haas MBA candidate Malu Kannuswamy. Editpep has developed a class of peptides capable of conveying CRISPR enzymes into clinically-relevant and previously untransfectable cell types.

MZR Neurotech, founded by Electrical Engineering and Computer Sciences Professor Rikky Muller, her postdoc Ryan Kaveh, and PhD candidates Saavan Patel and Arya Reais-Parsi. MZR has developed an in-ear EEG sensor for sleep monitoring and more.

“Berkeley LSEC and Berkeley SkyDeck share the same goals: to amplify and accelerate the growth of companies with world-changing potential. As expected, we had many prominent Berkeley faculty-led teams apply with cutting-edge IP and had to make some difficult decisions. We are excited to see how each of our first three alumni go on to succeed,” said Darren Cooke, Executive Director of Berkeley LSEC and the chair of the Bio Track at Berkeley SkyDeck.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Biotech, Biotech startups, Entrepreneurship, genomics, PhD

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |